Transcriptional Dysregulation and Post-translational Modifications in Polyglutamine Diseases: From Pathogenesis to Potential Therapeutic Strategies

Polyglutamine (polyQ) diseases are hereditary neurodegenerative disorders caused by an abnormal expansion of a trinucleotide CAG repeat in the coding region of their respective associated genes. PolyQ diseases mainly display progressive degeneration of the brain and spinal cord. Nine polyQ diseases...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiang, Chunchen, Zhang, Shun, Dong, Xiaoyu, Ma, Shuang, Cong, Shuyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962650/
https://www.ncbi.nlm.nih.gov/pubmed/29867345
http://dx.doi.org/10.3389/fnmol.2018.00153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5962650/
https://www.ncbi.nlm.nih.gov/pubmed/29867345
http://dx.doi.org/10.3389/fnmol.2018.00153

Ejemplares similares